GeniPhys
Advancing tissue restoration through polymerizable collagen.
Warsaw, United States · Founded 2019 · $7.7M raised
- Headquarters
- Warsaw, Indiana
- Employees
- 1–10
- Founded
- 2019
- Business Model
- B2B
- Website
- geniphys.com
- Total Funding
- $7.7M
- Last Round
- $500K GrantOct 2024
- Rounds
- 4
About
GeniPhys is a biotech company developing and commercializing Collymer™, a patented polymerizable collagen technology for tissue restoration and regeneration. Its materials support custom-designed scaffolds that promote new tissue formation while avoiding inflammation and fibrosis. Applications span soft tissue, cardiovascular, musculoskeletal, and orthopedic repair, as well as drug delivery and device coatings.
Summary
GeniPhys is a Medtech company based in Warsaw, United States, founded in 2019. It has raised $7.7M in total across 4 rounds, most recently a $500K Grant round in Oct 2024. Investors include National Science Foundation, Pier 70 Ventures and Elevate Capital.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2024
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...